Genome Editing: Technologies and Global Markets
The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.
- An overview of the global markets and technologies for genome editing, a promising new approach that can overcome the shortcomings from site-directed mutagenesis and recombination based methods using relatively simple concepts.
- Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- A focus on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products.
- Breakdowns of the market by region, industry, application, product and type, technology, and end-user.
- A look at the recent technical breakthrough on the use of CRISPR/Cas9 and how it has fueled the rapid growth of the genome editing industry.
- A look at other growth driving factors including: the need of precision medicine for accurate genome editing technology; the increased R&D expenditure in related industrial sectors (e.g. biopharma, agriculture, and energy); increased funding for genomics research and its technological advancements; increasing demand for synthetic genes in synthetic biology; Concerns that genetically modified crops can be reduced by applying gene editing technologies to non-trangenic plant breeding.
- Exploration of emerging ethical issues.
- A relevant patent analysis.
- Profiles of key players in the industry.
This study is focused on the market side of genome editing, along with a comprehensive review of genome editing technologies with related latest progresses in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and Rest of World.
Specifically, centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as its each segment. It details recent technical breakthroughs as well as major technical issues to overcome before the genome editing is applied to clinic applications. The growth driving factors and the factors that may limit the market’s growth are identified. The ethical issues, regulatory issues and intellectual property right issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.
Mike Fan is a life science marketing and product management professional with more than 20 years of experience cover multiple biotech R&D areas, as well as life science marketing in both academia and industry. Mike has a broad range of technical skills in chemical and biological area and holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.